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Clinicopathologic features and prognostic
grouping of gastrointestinal stromal tumors
(GISTs) in Pakistani patients: an institutional
perspective
Atif Ali Hashmi1, Mahrukh Faraz1, Zareeha Nauman1, Muhammad Usman Qureshi2, Shumaila Kanwal Hashmi3,
Hira Fatima Waseem1, Muhammad Muzzammil Edhi4, Naveen Faridi1 and Amir Khan5*

Abstract
Objectives: Gastrointestinal stromal tumors (GISTs) are rare tumors of gastrointestinal tract, prognosis of which
largely depends upon histopathologic characteristics of resection specimens, which were not widely studied in our
population. Therefore we aimed to evaluate the histopathologic characteristics of GISTs in our population and their
prognostic grouping according to college of American pathologist’s guidelines.
Results: Mean age of patients was 53.4 years (18–71 years). 92% of cases were of primary GISTs and stomach was the
most common site (57.7%). 75% of cases were of spindle cell morphology and 53.8% belonged to high risk prognostic
group. Comparison of stomach and intestinal GISTs showed that intestinal GISTs were found to be of high grade (70%)
and of high risk prognostic group (75 and 80%) compared to stomach GISTs (43% were of high risk prognostic group),
however this finding was not statistically significant. GISTs are infrequent gastrointestinal tumors but early diagnosis
and identification of adverse histological features are key to successful treatment. We found a large majority of GISTs
to be located in stomach, however intestinal GISTs were found more likely to be associated with adverse prognostic
parameters. However more large scale studies are warranted to establish this finding.
Keywords: Gastrointestinal stromal tumors, GISTs, Epitheloid GIST, Spindle cell GIST
Introduction
Gastrointestinal stromal tumors (GISTs) are the most
common mesenchymal tumors of the gut, however
overall they still account for < 1% of all gastrointestinal
tumors [1]. The clinical signs and symptoms of GISTs
are non-specific abdominal discomfort and distention,
therefore the diagnosis and treatment is usually delayed
leading to therapy failures and high morbidity and mortality rates. The incidence of GISTs at present is about 15
cases in 1 million in the United States and about 11 cases
in one million in Northern Europe. Although, the incidence of GISTs before 2000 is unknown; but the growing
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number of presenting cases has led to increased research
about this subject [2, 3]. The incidence of GISTs in our
country is unknown as large scale studies have not been
conducted.
Morphologically, the features of GIST resemble that
of leiomyoma and leiomyosarcoma and were previously
classified as such [4]. Almost all recent researches have
reached to the conclusion that GISTs can occur anywhere
throughout the digestive tract but most number of GIST
cases were recorded in the stomach [5].
The pathologic parameters of GISTs in resection specimens are important in guiding post-operative management and determining prognosis of the patients, however
these features have not been widely studied in our population. Only a few studies have been conducted in Pakistan. Ud Din et al. evaluated 255 cases of GIST and found
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62.3 gastric, 81.8% duodenal, 68% small intestinal, 72%
colorectal and 89% GISTs to be of high risk category [6].
Similarly Mushtaq et al. performed risk stratification on
36 cases of GIST. They found seven patients to fall into
low risk, ten patients intermediate risk, and 19 patients in
high risk groups. There were no patients in very low risk
group [7]. Therefore in this study we aimed to evaluate
clinicopathologic and prognostic parameters of GISTs in
our population which can help in devising personalized
therapeutic regimens for loco-regional population.

Main text
Materials and methods

A total of 52 cases of GISTs diagnosed and treated at Liaquat National hospital were included in the study from
2011 till 2016. An approval from institutional ethical
review committee was taken antecedent to conducting
the study. All cases were biopsy proven prior to definite
resection. After pre-operative workup, definite resection
was performed and specimens were sent to the pathology department. Gross and microscopic features of all
tumors were recorded including tumor size, site, tumor
morphology, grade, number of mitosis and prognostic
group according to College of American Pathologists
(CAP) guidelines.
Immunohistochemistry

Immunohistochemical markers including CKAE1/3,
ASMA, S100, CD34 and CD117 were performed by
DAKO envision method and slides were interpreted by
experienced pathologists. For CD117 IHC, polyclonal
Rabbit anti-human CD117, c-kit antibody was used purchased from DAKO and IHC was performed according
to DAKO envision method. Moderate to strong membranous staining in more than 10% tumor cells is considered
positive. For CD34, FLEX monoclonal anti-human CD34
class II, clone QBEnd 10, ready to use antibody was used.
For S100 IHC, FLEX polyclonal rabbit Anti-S100 ready
to use antibody was purchased from DAKO. Similarly,
for ASMA IHC, monoclonal anti-human Smooth muscle
actin, clone 1A4 antibody was used and performed using
DAKO envision kit according to manufacturer’s recommendations. Moderate to strong cytoplasmic staining in
more than 10% tumor cells was considered positive for
ASMA, S100 and CD34.
Statistical analysis

Statistical package for social sciences (SPSS 21) was used
for data compilation and analysis. Mean and standard
deviation were calculated for quantitative variables. Frequency and percentage were calculated for qualitative
variables. Chi square was applied to determine association. P-value of ≤ 0.05 was considered as significant.
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Results

Mean age of patients was 53.4 years (18–71 years) with a
slight male predominance. 92% of cases were of primary
GISTs and stomach was the most common site (57.7%).
75% of cases were of spindle cell morphology and 53.8%
belonged to high risk prognostic group as shown in
Table 1. Table 2 shows the comparison of GISTs at various
sites of digestive tract. Out of 48 cases of primary GISTs,
30 cases were seen in stomach, 10 in small intestine and 8
in large intestine. Out of 30 GISTs of stomach, 20 were in
the age group of > 50 years, 9 were seen in the age group
of 31–50 years and only 1 case of stomach GIST was seen
in age group of < 30 years. Similarly, in the small and large
intestine, the larger number of cases were seen in the age
group of > 50 years. The gender predominance was not
much appreciated, as equal number of cases of stomach
GIST was seen in both male and female. However, the
small and large intestines GISTs were seen to be more
common in males, however this finding was not statistically significant. Majority of the tumors were greater than
10 cm in size, however most GISTs in the stomach were
found to be 5–10 cm in size and most GISTs in the small
and large intestine were greater than 10 cm in size. 37
out of 48 cases were of spindle cell morphology. 20 out of
30 cases of stomach GIST were of spindle cell morphology, while 3 were epitheloid (Fig. 1) and 7 were of mixed
morphology. Almost all cases of small and large intestine
GIST were of spindle cell variety (Additional file 1: Figure
S1). 27 cases fell in the category of high risk category, 5
in the moderate risk, 11 in the low risk and 5 in the very
low risk. Majority of the cases displayed a mitotic activity
of greater than 5/50 HPF as a whole. 34 out of 46 tumors
were CD34 positive and 46 out of 48 were CD117 positive. 12 out of 40 were positive for S100 and 19 out of 43
were positive for ASMA. Hence, majority of the tumors
were positive for CD34 and CD117 and negative for S100
and ASMA as shown in Table 3.
Discussion/conclusion

GISTs have long been known to be mesenchymal tumors
of the gastrointestinal tract [2, 8]. Historically, they were
considered rare tumors mainly due to the reason that
they were mostly misdiagnosed owing to the similarities they shares with leiomyomas, leimyosarcomas and
schwannomas [9]. The misdiagnosis led to a bad prognosis and treatment failures. However, the attempts made
in the recent years to better understand the occurrence,
incidence and morphology of GIST has established the
fact that they are the most common mesenchymal tumor
of the GIT [1]. They can occur anywhere along the length
of the GIT, most common location of GIST occurrence
being the stomach [5].
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Table 1 Clinicopathologic characteristics of gastrointestinal
tumors (GISTs)
Characteristic

Frequency (%)

Gender
Male

32 (61.5%)

Female

20 (38.51%)

Age (years)
Mean

53.4 (18–71 years)

Age groups (years)
  < 30

3 (5.8%)

  31–50

18 (34.61%)

  > 50

31 (59.6%)

Primary/metastatic
Primary

48 (92.3%)

Metastasis

4 (7.74%)

Site
Stomach

30 (57.7%)

Small intestine

10 (19.2%)

Large intestine

08 (15.4%)

Liver

04 (7.7%)

Size (cm)
Mean

9.4 (2–16)

Size groups (cm)
  < 2

1 (1.9%)

  2–5

6 (11.5%)

  5–10

20 (35.5%)

  > 10

22 (42.3%)

Morphology
Spindle

39 (75%)

Eptheloid

4 (7.5%)

Mixed

9 (17.3%)

Grade (mitotic activity)
Low grade (< 5/50HPFs)

23 (44.2%)

High grade (> 5/50HPFs)

29 (55.8%)

Necrosis
Present

10 (19.2%)

Absent

42 (80.8%)

Prognostic groups
Very low risk

5 (9.63%)

Low risk

11 (21.2%)

Moderate risk

5 (9.6%)

High risk

28 (53.8%)

In this study, we specifically compared the general
characteristics of GIST with respect to the location and
the histochemical markers (as they have proved to be in
an essential tool for the diagnosis of GIST) and compared
them with previously published literature.
Although most of the literature quotes the presence
of GIST in esophagus, stomach, intestine, rectum and

mesentery; in this study of 48 cases of primary GIST,
the occurrence was seen in stomach, small intestine and
large intestine only. As per previous studies, stomach
predominated with 62.5% followed by small intestine
(20.8%) and large intestine (16.7%). This was consistent
with the findings of most of the other Asian literature.
GISTs were seen to be more common in the older
age adults of greater than 50 years and very rarely seen
in young adults of less than 30 years. Some cases were
also seen in the age group of 30–50 but it was not so
commonly seen in this age group, mean age of stomach
GIST being 54.50, 52.10 of small intestine and 55.25
of large intestine. Although not statistically significant
(P = 0.785) but in accordance with other studies done,
we can say that GIST is most likely to occur in older age
adults of greater than 50 years [10–12].
Male and female genders were equally affected by
stomach GIST (50% cases were reported in both), however the intestinal GIST were predominantly seen in
males than females (80% vs 20% in small intestine and
75% vs 25% in large intestine). Although other Asian
studies did show slight male to female dominance [10,
11, 13], in this study no statistical significance was seen
(P = 0.159).
GISTs usually involve the entire thickness of the gastrointestinal wall [14, 15], this owes to the fact that they are
usually larger in size, as established in this study where
majority of the tumors were greater than 10 cm and
scarcely less than 5 cm. The reason behind the large size
of the tumor might be its relatively silent clinical course
[10]. However, the mean size of the tumor in the stomach
was seen to be 8.96 and 10.20 and 10.28 in the small and
large intestine respectively. Although, not statistically
significant (P = 0.570) it can be noticed that majority of
the tumors in the stomach ranged from 5 to 10 cm in size
and majority of the intestinal tumors were greater than
10 cm. Some other Asian studies have also mentioned the
mean size of the tumor to be > 5 cm [13, 16].
On histology, the majority tumors composed of spindle cells (77%) arranged in interlacing pattern forming
whorls, with abundant eosinophilic cytoplasm. Epitheloid
and mixed varieties were rarely seen, however among
these two, the mixed variety predominated (10% and
35.8% respectively); although epitheloid type has been
mentioned to be more common than mixed in the previous literatures [15] but our finding was consistent with
the findings of Asian literature in which mixed variety
predominated [10, 11]. Nonetheless, spindle variety was
most common finding in all studies. Although not statistically significant, but it was noted that the stomach contained all three types of morphology patterns while 100%
of the cases of the small intestinal GISTs were of spindle
cell morphology and the large intestinal GISTS were seen
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Table 2 Comparison of clinicopathologic features of gastrointestinal stromal tumors (GISTs) of various sites
Variables

Stomach

Small intestine

Large intestine

N (%)

N (%)

N (%)

P-value

54.50 ± 11.99

52.10 ± 15.53

55.25 ± 14.29

0.852
0.785

Age (years)
Mean ± SD

Age groups (years)

1 (3.3)

1 (10)

0

31–50

≤ 30

9 (30)

4 (40)

3 (37.5)

> 50

20 (66.7)

5 (50)

5 (62.5)

Gender
Male

15 (50)

8 (80)

6 (75)

Female

15 (50)

2 (20)

2 (25)

0.159

8.96 ± 3.94

10.20 ± 4.75

10.28 ± 3.11

0.570
0.287

Size
Mean ± SD

Size groups (cm)
≤2

2.1–5

0

1 (10)

0

4 (13.3)

1 (10)

1 (12.5)

5.1–10

15 (50)

2 (20)

2 (25)

> 10

11 (36.7)

6 (60)

5 (62.5)

Morphology
Spindle cell

20 (66.7)

10 (100)

7 (87.5)

Eptheloid

3 (10)

0

0

Mixed

7 (23.3)

0

1 (12.5)

0.318

Prognostic group
Very low risk

4 (13.3)

1 (10)

0

Low risk

10 (33.3)

0

1 (12.5)

Moderate risk

3 (10)

1 (10)

1 (12.5)

High risk

13 (43.3)

8 (80)

6 (75)

0.214

Grade (mitotic activity)
Low grade (≤ 5/50HPFs)

15 (50)

3 (30)

5 (62.5)

High grade (> 5/50HPFs)

15 (50)

7 (70)

3 (37.5)

to have spindle and mixed morphology (87.5 and 12.5%
respectively).
According to Asian studies, most of the GISTs overall
were low grade tumors [11] and most showed high risk
features followed by intermediate and low risk [12, 13,
17]. In our study, majority of the stomach GISTs were
seen to be of high risk (43.3%), followed by low risk, very
low risk and moderate risk. However, the greatest high
risk tumors were in the small intestine (80%) and large
intestine (75%).
For the purpose of studying the immunohistochemical features of the GISTs, two types of antibodies were
used: one with high specificity for GISTs, such as CD117
and CD34, and other which are more specific for smooth
muscle tumors and neural tumors (ASMA and S-100), as
these two types of tumors are the ones which are most
often misdiagnosed as GISTs.

0.456

S-100 was positive in 12 cases, negative in 28, not
performed in 8. ASMA was positive in 19 cases, negative in 24 and not performed in 5. CD34 was positive in
34 cases, negative in 12 and not performed in 2. CD117
was positive in 46 cases and negative in 2. These findings are consistent with many other Asian studies in
which CD117 and CD34 positivity has been seen in
most GISTs, followed by ASMA and S-100 [10, 13, 16,
18].
While, most of the stomach GISTs were negative for
ASMA (70.8%) and S-100 (64.3%) and positive for CD34
and CD117 (as well as most of small intestine tumors
were positive for both), most of the large intestine GISTs
were seen to be positive for ASMA (26.3%) and negative for CD34 (41.7%). Most of the spindle cell variety
was negative for ASMA (83.3%) and positive for CD34
(73.5%) and most of the epitheloid and mixed variety
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Fig. 1 Gastrointestinal stromal tumor, Epitheloid subtype: A–C H&E sections showing sheets of epitheloid cells with marked atypia. D Diffuse
expression of CD117 noted in tumor cells

were positive for ASMA (10.5 and 26.3%) and CD34 negativity was noticed in most epitheloid type variety. Most
of the high risk tumors were negative (62.5%) and low
risk tumors were positive (31.6%) for ASMA.
A statistically significant finding was seen in CD34
positivity with respect to site of the tumor (P = 0.013)
and CD117 positivity with respect to the morphology
of the tumor (P = 0.024); other findings however, were
not statistically significant.
Liu et al. compared 300 cases of duodenal GISTs
with gastric GISTs and found them to be significantly
associated with worse prognostic features [19]. Similarly Zhu et al. compared colorectal GISTs with gastric
GISTs. They found rectal GISTs to be associated with
improved overall survival while colonic GISTs were

associated with worse overall survival [20]. On the
other hand Feng et al. studied small intestinal GISTs
and found jejunal and ileal GISTs to be comparable in
terms of prognosis [21].

Limitations
GISTs are infrequent gastrointestinal tumors but early
diagnosis and identification of adverse histological features are key to successful treatment. We found a large
majority of GISTs to be located in stomach, however
intestinal GISTs were found more likely to be associated with adverse prognostic parameters. One of the
major limitations of the study was small sample size
and lack of clinical follow up to determine disease free
survival and recurrence. Therefore we suggest that,

9 (75.0)

1 (8.3)

2 (16.7)

0

7 (58.3)

5 (41.7)

2 (16.7)

1 (8.3)

9 (75)

2 (16.7)

3 (25.0)

7 (58.3)

15 (53.6)

3 (10.7)

6 (21.4)

4 (14.3)

11 (39.3)

17 (60.7)

5 (17.9)

2 (7.1)

21 (75.0)

6 (21.4)

4 (14.3)

18 (64.3)

3 (37.5)

1 (12.5)

3 (37.5)

1 (12.5)

1 (12.5)

7 (87.5)

1 (12.5)

0

7 (87.5)

0

3 (37.5)

5 (62.5)

* Significant at 0.05 level

P represents positive, N represents negative, ND represents not done

High risk (n = 27)

Moderate risk (n = 5)

Low risk (n = 11)

Very low risk (n = 5)

Prognostic group

High (n = 19)

Low (n = 29)

Grade

Mixed (n = 8)

Eptheloid (n = 3)

Spindle cell (n = 37)

Morphology

Large intestine (n = 8)

Small intestine
(n = 10)

Stomach (n = 30)

Site

ASMA

CD34

CD117

0.668

0.123

1.000

0.515

10 (52.6)

2 (10.5)

6 (31.6)

1 (5.3)

8 (42.1)

11 (57.9)

5 (26.3)

2 (10.5)

12 (63.2)

5 (26.3)

4 (21.1)

10 (52.6)

15 (62.5)

2 (8.3)

4 (16.7)

3 (12.5)

11 (45.8)

13 (54.2)

3 (12.5)

1 (4.2)

20 (83.3)

3 (12.5)

4 (16.7)

17 (70.8)

2 (40)

1 (20)

1 (20)

1 (20)

0

5 (100)

0

0

5 (100)

0

2 (40.0)

3 (60.0)

0.681

0.220

0.462

0.469

16 (47.1)

4 (11.8)

10 (29.4)

4 (11.8)

11 (32.4)

23 (67.6)

8 (23.5)

1 (2.9)

25 (73.5)

3 (8.8)

6 (17.6)

25 (73.5)

10 (83.3)

1 (8.3)

1 (8.3)

0

7 (58.3)

5 (41.7)

0

2 (16.7)

10 (83.3)

5 (41.7)

4 (33.3)

3 (25.0)

1 (50.0)

0

0

1 (50.0)

1 (50.0)

1 (50.0)

0

0

2 (100)

0

0

2 (100)

0.190

0.263

0.137

0.013*

25 (54.3)

5 (10.9)

11 (23.9)

5 (10.9)

17 (37.0)

29 (63.0)

7 (15.2)

2 (4.3)

37 (80.4)

8 (17.4)

10 (21.7)

28 (60.9)

2 (100)

0

0

0

2 (100.0)

0

1 (50.0)

1 (50.0)

0

0

0

2 (100)

1.000

0.152

0.024*

1.000

P (n = 12) N (n = 28) ND (n = 8) P-value P (n = 19) N (n = 24) ND (n = 5) P-value P (n = 34) N (n = 12) ND (n = 2) P-value P (n = 46) N (n = 2) P-value

S100

Table 3 Immunohistochemal features of gastrointestinal tumors (GISTs)
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more large scale studies are warranted to establish the
findings of our study.

Additional file
Additional file 1: Figure S1. Gastrointestinal tumor, spindle cell subtype:
(A, B) H&E sections showing sheets of spindled cells with elongated nuclei.
C, D Tumor cells show CD117 and CD34 positivity.
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